Neostigmine Methylsulfate Injection recall: Sterility Concern
Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe…
Why was Neostigmine Methylsulfate Injection recalled?
Lack of Assurance of Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: NE2001A, Exp. 6/30/2022; NE2009B, Exp. 8/27/2022
- Product
- Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe…
- Recalling firm
- Nephron Sterile Compounding Center LLC
- Quantity
- 64450 syringes
- Distribution
- Nationwide in the USA
- Recall date
- June 8, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)